HS-10365

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10365, covering 2023-06-01 to 2023-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]